1-10 of 10
Authors: Arati S Desai
Journal Article
ACCEPTED MANUSCRIPT
Incidence, management, and outcomes of procarbazine-associated hypersensitivity reactions in patients receiving PCV for lower-grade gliomas Get access
Neuro-Oncology Practice, npaf046, https://doi.org/10.1093/nop/npaf046
Published: 28 April 2025
Journal Article
A single-arm phase 2 study of abemaciclib in adult patients with recurrent grade 3 oligodendroglioma Open Access
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf011, https://doi.org/10.1093/noajnl/vdaf011
Published: 17 January 2025
Journal Article
Machine learning-based prognostic subgrouping of glioblastoma: A multicenter study Get access
Neuro-Oncology, Volume 27, Issue 4, April 2025, Pages 1102–1115, https://doi.org/10.1093/neuonc/noae260
Published: 12 December 2024
Journal Article
Risk of intracranial hemorrhage with direct oral anticoagulants vs low molecular weight heparin in glioblastoma: A retrospective cohort study Free
Neuro-Oncology, Volume 24, Issue 12, December 2022, Pages 2172–2179, https://doi.org/10.1093/neuonc/noac125
Published: 12 May 2022
Journal Article
Association of plasma cell-free DNA with survival in patients with IDH wild-type glioblastoma Open Access
Neuro-Oncology Advances, Volume 3, Issue 1, January-December 2021, vdab011, https://doi.org/10.1093/noajnl/vdab011
Published: 16 January 2021
Journal Article
Imaging and histopathologic correlates of plasma cell-free DNA concentration and circulating tumor DNA in adult patients with newly diagnosed glioblastoma Open Access
Neuro-Oncology Advances, Volume 2, Issue 1, January-December 2020, vdaa016, https://doi.org/10.1093/noajnl/vdaa016
Published: 27 February 2020
Journal Article
EDITOR'S CHOICE
CAR T-cell therapy for glioblastoma: recent clinical advances and future challenges Free
Neuro-Oncology, Volume 20, Issue 11, November 2018, Pages 1429–1438, https://doi.org/10.1093/neuonc/noy032
Published: 02 March 2018
Journal Article
PATH-02. USE OF RNAseq TO IDENTIFY TUMOR CELL AND MICROENVIRONMENT FACTORS ASSOCIATED WITH IMMUNE CYTOLYTIC ACTIVITY IN GLIOBLASTOMA Free
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Pages vi170–vi171, https://doi.org/10.1093/neuonc/nox168.693
Published: 06 November 2017
Journal Article
Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas Free
Neuro-Oncology, Volume 19, Issue 6, 1 June 2017, Pages 845–852, https://doi.org/10.1093/neuonc/nox020
Published: 22 March 2017
Journal Article
NIMG-35RESULTS OF EXPLORATORY 18F-FLT PET IMAGING IN TEN RECURRENT HIGH-GRADE GLIOMA PATIENTS TREATED WITH THE SELECTIVE T-TYPE CALCIUM CHANNEL BLOCKER MIBEFRADIL FOLLOWED BY TEMOZOLOMIDE (ABTC TRIAL 1101) Free
Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Page v161, https://doi.org/10.1093/neuonc/nov225.35
Published: 09 November 2015
